_esmo-e-learning-first-line-immunotherapy-for-oesophageal-and-gastric-cancer-as-new-standard-of-care.jpg "ESMO e-Learning: First Line Immunotherapy for Oesophageal and Gastric Cancer as New Standard of Care from immunotherapy in cancer Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 16 min 93 sec
✓ Published: 02-Jun-2022
✓ Published: 02-Jun-2022
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_the-latest-lung-cancer-research-updates-from-asco-2022.webp "Dr. Tejas Patil from the University of Colorado Cancer Center shares the latest news in lung cancer research and treatment from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, including an update on immunotherapy. nnDr. Tejas Patil is an academic thoracic oncologist at the University of Colorado Cancer Center focused on targeted therapies and novel biomarkers in lung cancer. Learn more about Dr. Patil, here: http://cudoctors.com/Find_A_Doctor/Profile/24489.")
_lung-cancer-treatment-approaches-what-are-your-options.webp "How is lung cancer treated? Dr. Jessica Bauman provides an overview of lung cancer treatment modalities, including surgery, radiation and systemic therapies such as chemotherapy, immunotherapy, and targeted therapy. nnDr. Jessica Bauman is assistant professor in the department of hematology/oncology and as associate program director of the hematology/oncology fellowship training program at Fox Chase Cancer Center in Philadelphia. Learn more about Dr. Bauman here: https://www.foxchase.org/jessica")
_2009-career-achievement-medal-recipient.webp "For more than five decades, Dr. Thomas Waldmann has performed cutting-edge science at the National Institutes of Health, resulting in great advances in treatment for patients with multiple sclerosis, various types of cancer and AIDS.nnDescribed by his peers as a “renaissance scientist,” Waldmann’s work extends from the study of the immune system to innovative clinical trials of immunotherapeutic agents, which help your immune system perform better. Cancer immunotherapy, for example, helps")
_why-choose-medical-oncology-trainee-perspective.webp "Dr Shanthini Crusz (Barts Cancer Institute, London, UK), Dr Sarah Duncan (Royal Free Hospital, London, UK), Dr Steve Kihara (Loughborough University, Loughborough, UK), Dr Anna Olsson-Brown (The Clatterbridge Cancer Centre & The University of Liverpool, Liverpool, UK), Dr Jonathan Lim (The Christie NHS Foundation Trust, Manchester, UK), Dr Emily Goode (Royal Marsden and ICR, London, UK) and Dr Edward Armstrong (Royal Marsden Hospital, London, UK) spoke with ecancer at the ACP immun")
_efficacy-and-immune-correlates-of-the-sra737-plus-ldg-regimen-in-combination-with-anti-pd-l1-in-an-sclc-model.webp "Dr Triparna Sen speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about results from a study looking at the efficacy and correlates of immunity of the combination treatment involving CHK1 inhibitor SRA737 plus low dose gemcitabine with anti-PDL1 in a model of small cell lung cancer (SCLC).nnShe explains that SCLC is very good at hiding itself from the immune system causing most of the immunotherapy drugs so far to have modest benefit.nnDr Sen reports that this")
⏲ 3 min 27 sec ✓ 09-Apr-2019
_new-zealand-innovators-awards-2015-winner-of-supreme-new-zealand-innovator-kode-biotech.webp "Kode Biotech has been focused on the development of cell surface membrane modification technology in the fight against tumours. Synthetic animal antigens are used to modify the cancer cell surface membrane and encourage the body’s natural immune response to attack the cancer tumour cells. Kode Biotech’s lipid technology will be used in Agalimmune’s clinical human trials of their cancer immunotherapy molecules in 2016.")
⏲ 1 min 66 sec ✓ 07-Dec-2015
_the-role-of-immunotherapy-in-metastatic-esophageal-and-gastroesophageal-cancer.webp "The Role of Immunotherapy in Metastatic Esophageal and Gastroesophageal Cancer from immunotherapy in cancer")
⏲ 61 min 52 sec ✓ 17-Feb-2022
_what-do-advanced-non-melanoma-skin-cancer-patients-need-to-know-about-treatment-and-research.webp "What therapies are emerging for advanced non-melanoma skin cancer (ANMSC)? Dr. Anna Pavlick shares the latest in ANMSC research news, including developments in targeted therapy and immunotherapy.nnDr. Anna Pavlick is a medical oncologist with over 20 years of experience treating patients with skin cancer and is the founding Director of the Cutaneous Oncology Program at Weill Cornell Medicine and NewYork-Presbyterian. To learn more about Dr. Pavlick, visit: https://weillcornell.org/anna-c-pavlick")
⏲ 2 min 69 sec ✓ 19-Oct-2022
Related Video Searches
Back to Search
Search Videos
Recent Searches
×
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
_the-latest-lung-cancer-research-updates-from-asco-2022.jpg)
_lung-cancer-treatment-approaches-what-are-your-options.jpg)
_2009-career-achievement-medal-recipient.jpg)
_why-choose-medical-oncology-trainee-perspective.jpg)
_efficacy-and-immune-correlates-of-the-sra737-plus-ldg-regimen-in-combination-with-anti-pd-l1-in-an-sclc-model.jpg)
_new-zealand-innovators-awards-2015-winner-of-supreme-new-zealand-innovator-kode-biotech.jpg)
_the-role-of-immunotherapy-in-metastatic-esophageal-and-gastroesophageal-cancer.jpg)
_what-do-advanced-non-melanoma-skin-cancer-patients-need-to-know-about-treatment-and-research.jpg)
❮❯
1 / 10
2 / 10
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
3 / 10
4 / 10
5 / 10
6 / 10
7 / 10
8 / 10
9 / 10
10 / 10
![[+]](/images/menu.gif){kind=small}